The BLCA cases with higher EPHA3 expression levels showed a noticeably better OS rate in the GSE48075 cohort (p = 0.027, HR = 0.43 (0.16–1.16); Figure 3A). The gene discussed is EPHA3; the disease is bladder transitional cell carcinoma.